What is vv ecmo

How VV ECMO Works

VV ECMO is an advanced life-support therapy that partially or fully takes over the function of the lungs. Blood is withdrawn from a large vein in the neck or groin, passed through an artificial membrane that oxygenates it while removing carbon dioxide, then returned to another vein. This veno-venous configuration allows the patient's heart to continue circulating blood, supporting severely compromised respiratory function.

Clinical Indications

VV ECMO is indicated for severe acute respiratory distress syndrome (ARDS), acute lung injury, and respiratory failure unresponsive to conventional mechanical ventilation. During the COVID-19 pandemic, VV ECMO became a critical intervention for patients with severe pneumonia and respiratory failure. The therapy provides time for lungs to recover or allows patients to reach a lung transplant evaluation and transplantation.

Medical Management

Managing VV ECMO patients requires intensive ICU care and specialized expertise. Anticoagulation is essential to prevent clot formation in the circuit, requiring careful monitoring of bleeding and clotting times. Complications can include bleeding, infection, hemolysis, and circuit thrombosis. Trained teams continuously monitor oxygenation, carbon dioxide removal, pump flow, and patient stability. Weaning protocols are gradual, testing the lung's recovery capability before discontinuation.

Outcomes and Prognosis

Survival rates for VV ECMO vary based on underlying cause and patient factors, ranging from 40-60% in experienced centers. The intensive nature and cost of ECMO therapy make it suitable only for appropriate candidates likely to benefit. Success depends on early identification of respiratory failure, rapid ECMO initiation, expert management, and favorable underlying lung pathology with recovery potential.